- ACR •
- 14 November, 2024 •
- •
Safety and Efficacy of SEL-212 in the US and ex-US Subgroups: Results from the Phase 3 DISSOLVE Studies
Michael Pillinger, Alan Kivitz, Atul Singhal, Anand Patel, Rehan Azeem, Aletta Falk, Bhavisha Desai, Hugues Santin-Janin, Herbert Baraf
Available materials